marketcaparena

DTIL

PRECISION BIOSCIENCES INC

Company overview

Market capitalization
$172.23M
Employees
66
Latest publication
2026-09-29
About PRECISION BIOSCIENCES INC

Precision BioSciences, Inc., a clinical stage gene editing company, develops in vivo gene editing therapies for gene edits, including gene insertion, excision, and elimination in the United States. The company offers ARCUS, a genome editing platform for DNA genome insertion, removal, and repair. It also provides PBGENE-HBV for the treatment of chronic hepatitis B virus (HBV) to eliminate covalently closed circular DNA with direct cuts and edits, as well as to inactivate integrated HBV DNA with the goal of long-lasting reductions in hepatitis B surface antigen; and PBGENE-DMD (Excision) for the treatment of Duchenne muscular dystrophy. In addition, the company develops PBGENE-3243 for the treatment of m.3243 associated mitochondrial diseases; and iECURE-OTC (Insertion) for ornithine transcarbamylase deficiency. It has collaboration agreements with TG Cell Therapy, Inc. to develop, manufacture, and commercialize azercabtagene zapreleucel for autoimmune diseases and other indications; and iECURE, Inc., an ARCUS-mediated targeted gene insertion. Precision BioSciences, Inc. was incorporated in 2006 and is headquartered in Durham, North Carolina.

Company website

Financial statements

Income Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ4 20232023-12-31 · USD
Total Revenue0USD10,838,000USD34,204,000USD13,000USD18,000USD29,000USD638,000USD7,038,000USD
Research Development12,394,000USD13,110,000USD14,464,000USD13,352,000USD12,768,000USD13,588,000USD15,907,000USD13,389,000USD
General And Administrative Expenses6,767,000USD———————
Total Operating Expenses19,161,000USD19,913,000USD21,696,000USD20,680,000USD21,895,000USD22,141,000USD25,484,000USD21,928,000USD
Operating Income-19,161,000USD-9,075,000USD12,508,000USD-20,667,000USD-21,877,000USD-22,112,000USD-24,846,000USD-14,890,000USD
Total Other Income Expense Net-13,491,000USD-9,366,000USD6,740,000USD-1,105,000USD-1,643,000USD1,547,000USD7,101,000USD1,456,000USD
Interest Expense300,000USD311,000USD348,000USD362,000USD358,000USD354,000USD392,000USD579,000USD
Equity Method Income Loss0USD———————
Net Income-32,652,000USD-18,441,000USD20,133,000USD-21,772,000USD-23,520,000USD-20,565,000USD-17,745,000USD-16,289,000USD
Gross Profit—10,838,000USD34,204,000USD13,000USD18,000USD29,000USD638,000USD7,038,000USD
Selling General Administrative—6,803,000USD7,232,000USD7,328,000USD9,127,000USD8,553,000USD9,577,000USD8,539,000USD
Interest Income—999,000USD773,000USD1,027,000USD1,116,000USD1,323,000USD1,494,000USD1,827,000USD
Net Interest Income—688,000USD425,000USD665,000USD758,000USD969,000USD1,102,000USD1,248,000USD
Income Before Tax—-18,441,000USD19,248,000USD-21,772,000USD-23,520,000USD-20,565,000USD-17,745,000USD-13,434,000USD
Net Income From Continuing Ops—-18,441,000USD19,248,000USD-21,772,000USD-23,520,000USD-20,565,000USD-17,745,000USD-13,434,000USD
Ebit—-18,130,000USD19,596,000USD-21,410,000USD-23,162,000USD-20,211,000USD-17,353,000USD-12,855,000USD
Ebitda—-17,490,000USD20,274,000USD-20,736,000USD-22,466,000USD-19,506,000USD-16,596,000USD-11,299,000USD
Depreciation And Amortization—640,000USD678,000USD674,000USD696,000USD705,000USD757,000USD1,556,000USD
Reconciled Depreciation—640,000USD678,000USD674,000USD696,000USD705,000USD757,000USD1,556,000USD
Cost Of Revenue——678,000USD674,000USD696,000USD—757,000USD1,556,000USD
Income Tax Expense——————-1,724USD2,855,000USD
Selling And Marketing Expenses———————592,000USD
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Income Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20212021-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USD
Total Revenue34,264,000USD68,696,000USD115,529,000USD6,484,000USD7,015,000USD
Cost Of Revenue2,753,000USD4,577,000USD—0USD0USD
Gross Profit34,264,000USD68,696,000USD115,529,000USD6,484,000USD7,015,000USD
Research Development54,172,000USD59,559,000USD115,238,000USD20,324,000USD9,102,000USD
Selling General Administrative32,240,000USD35,299,000USD39,667,000USD8,016,000USD6,168,000USD
Total Operating Expenses86,412,000USD94,858,000USD154,905,000USD28,340,000USD15,203,000USD
Operating Income-52,148,000USD-26,162,000USD-39,376,000USD-21,974,000USD-8,828,000USD
Interest Income4,239,000USD6,763,000USD208,000USD872,000USD570,000USD
Interest Expense1,422,000USD1,782,000USD132,000USD0USD0USD
Net Interest Income2,817,000USD4,981,000USD76,000USD872,000USD—
Income Before Tax-46,609,000USD7,167,000USD-30,602,000USD-21,102,000USD-8,256,000USD
Net Income-45,724,000USD7,167,000USD-30,602,000USD-21,102,000USD-8,251,000USD
Net Income From Continuing Ops-46,609,000USD7,167,000USD-30,602,000USD-21,102,000USD-8,251,000USD
Ebit-45,187,000USD8,949,000USD-30,470,000USD-21,856,000USD-8,828,000USD
Ebitda-42,434,000USD13,526,000USD-20,273,000USD-20,421,000USD-8,188,000USD
Depreciation And Amortization2,753,000USD4,577,000USD10,197,000USD1,435,000USD640,000USD
Reconciled Depreciation2,753,000USD4,577,000USD10,197,000USD1,435,000USD—
Total Other Income Expense Net5,539,000USD33,329,000USD8,774,000USD872,000USD572,000USD
Income Tax Expense——316,000USD-754,000USD-5,000USD
Non Operating Income Net Other——8,800,000USD——
Net Income Applicable To Common Shares——-30,602,000USD-21,102,000USD-8,251,000USD
Tax Provision————-5,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
Total Assets125,920,000USD143,891,000USD154,416,000USD93,510,000USD108,928,000USD124,411,000USD136,388,000USD153,258,000USD
Cash And Equivalents86,076,000USD———————
Cash And Short Term Investments87,549,000USD101,184,000USD115,585,000USD44,870,000USD62,242,000USD77,223,000USD86,312,000USD101,202,000USD
Short Term Investments1,473,000USD1,814,000USD4,762,000USD0USD0USD0USD413,000USD2,450,000USD
Total Current Assets91,549,000USD108,693,000USD118,740,000USD51,705,000USD70,259,000USD82,103,000USD94,989,000USD110,523,000USD
Other Current Assets5,000USD3,509,000USD3,155,000USD6,831,000USD8,017,000USD4,876,000USD6,979,000USD7,774,000USD
Other Non Current Assets126,000USD———————
Total Liabilities80,627,000USD———————
Total Current Liabilities7,140,000USD7,755,000USD8,913,000USD14,996,000USD13,568,000USD12,393,000USD14,980,000USD11,982,000USD
Other Current Liabilities588,000USD———————
Other Non Current Liabilities301,000USD———————
Total Stockholder Equity45,293,000USD76,101,000USD92,248,000USD16,634,000USD34,054,000USD49,337,000USD56,393,000USD64,866,000USD
Total Equity Including Noncontrolling Interest45,293,000USD———————
Net Receivables0USD4,000,000USD0USD4,000USD5,730,000USD4,000USD1,698,000USD1,547,000USD
Property Plant Equipment Net6,078,000USD6,647,000USD7,230,000USD8,164,000USD8,818,000USD9,497,000USD10,179,000USD10,956,000USD
Intangible Assets1,093,000USD1,127,000USD1,166,000USD985,000USD605,000USD607,000USD622,000USD388,000USD
Accounts Payable828,000USD944,000USD296,000USD1,340,000USD1,121,000USD924,000USD1,312,000USD958,000USD
Short Term Debt1,608,000USD1,557,000USD1,507,000USD2,916,000USD1,411,000USD1,365,000USD1,320,000USD1,275,000USD
Common Stock1,000USD1,000USD1,000USD1,000USD1,000USD1,000USD1,000USD1,000USD
Retained Earnings-579,281,000USD-546,629,000USD-528,188,000USD-548,321,000USD-526,549,000USD-503,029,000USD-482,464,000USD-464,719,000USD
Total Liab—67,790,000USD62,168,000USD76,876,000USD74,874,000USD75,074,000USD79,995,000USD88,392,000USD
Other Current Liab—5,254,000USD7,110,000USD5,950,000USD5,047,000USD4,373,000USD9,391,000USD9,574,000USD
Capital Stock—0USD1,000USD1,000USD1,000USD1,000USD1,000USD1,000USD
Other Assets—1USD——————
Cash—99,370,000USD110,823,000USD44,870,000USD62,242,000USD77,223,000USD85,899,000USD98,752,000USD
Net Debt—-70,904,000USD-82,015,000USD-15,742,000USD-32,797,000USD-47,475,000USD-55,854,000USD-68,445,000USD
Short Long Term Debt Total—28,466,000USD28,808,000USD29,128,000USD29,445,000USD29,748,000USD30,045,000USD30,307,000USD
Common Stock Shares Outstanding—24,634,443shares19,171,669shares11,818,145shares11,046,401shares8,965,156shares6,883,911shares7,287,173shares
Non Current Assets Total—35,197,999USD35,676,000USD41,805,000USD38,669,000USD42,308,000USD41,399,000USD42,735,000USD
Non Current Liabilities Total—60,035,000USD53,255,000USD61,880,000USD61,306,000USD62,681,000USD65,015,000USD76,410,000USD
Non Current Liabilities Other—60,035,000USD259,000USD227,000USD200,000USD197,000USD194,000USD188,000USD
Non Currrent Assets Other—202,999USD26,536,000USD200,000USD28,502,000USD28,998,000USD27,392,000USD28,185,000USD
Net Working Capital—100,938,000USD109,827,000USD36,709,000USD56,691,000USD69,710,000USD80,009,000USD98,541,000USD
Unclassified Non Current Assets—27,220,999USD—31,712,000USD————
Unclassified Equity—622,729,000USD620,434,000USD564,953,000USD560,601,000USD552,364,000USD538,855,000USD529,583,000USD
Long Term Debt——22,404,000USD22,374,000USD22,354,000USD22,337,000USD22,321,000USD22,278,000USD
Long Term Investments——744,000USD744,000USD744,000USD3,206,000USD3,206,000USD3,206,000USD
Property Plant Equipment Gross——35,922,000USD8,164,000USD8,818,000USD9,497,000USD38,255,000USD10,956,000USD
Unclassified Non Current Liabilities——30,592,000USD39,279,000USD38,752,000USD40,147,000USD42,500,000USD53,944,000USD
Current Deferred Revenue———6,248,000USD5,989,000USD5,731,000USD2,957,000USD175,000USD
Unclassified Current Liabilities———-1,458,000USD————
Good Will————605,000USD607,000USD——
Unclassified Current Assets————-5,730,000USD———
SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Balance sheet Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Total Assets154,416,000USD136,388,000USD159,781,000USD238,169,000USD211,498,000USD150,158,000USD235,233,000USD138,600,000USD
Intangible Assets1,166,000USD622,000USD400,000USD731,000USD2,048,000USD1,373,000USD1,432,000USD1,466,000USD
Other Current Assets3,155,000USD6,979,000USD6,883,000USD8,809,000USD17,603,000USD5,766,000USD11,821,000USD11,959,000USD
Total Liab62,168,000USD79,995,000USD140,920,000USD177,736,000USD120,330,000USD105,733,000USD96,919,000USD98,640,000USD
Total Stockholder Equity92,248,000USD56,393,000USD18,861,000USD60,433,000USD91,168,000USD44,425,000USD138,314,000USD39,960,000USD
Other Current Liab7,110,000USD9,391,000USD11,439,000USD11,141,000USD11,770,000USD9,868,000USD8,409,000USD3,421,000USD
Common Stock1,000USD1,000USD1,000USD1,000USD————
Capital Stock1,000USD1,000USD1,000USD1,000USD0USD0USD0USD0USD
Retained Earnings-528,188,000USD-482,464,000USD-489,631,000USD-428,312,000USD-316,675,000USD-286,073,000USD-177,067,000USD-85,187,000USD
Cash110,823,000USD85,899,000USD116,678,000USD189,576,000USD143,663,000USD89,798,000USD180,886,000USD103,193,000USD
Cash And Short Term Investments115,585,000USD86,312,000USD116,678,000USD189,576,000USD143,663,000USD89,798,000USD180,886,000USD103,193,000USD
Total Current Assets118,740,000USD94,989,000USD136,359,000USD199,105,000USD161,754,000USD105,564,000USD193,672,000USD115,675,000USD
Total Current Liabilities8,913,000USD14,980,000USD49,987,000USD59,664,000USD35,980,000USD42,829,000USD26,932,000USD14,075,000USD
Net Debt-82,015,000USD-55,854,000USD-85,410,000USD-164,616,000USD-134,550,000USD-79,279,000USD-180,886,000USD-103,193,000USD
Short Term Debt1,507,000USD1,320,000USD23,545,000USD1,678,000USD1,822,000USD1,933,000USD6,825,000USD3,251,000USD
Short Long Term Debt Total28,808,000USD30,045,000USD31,268,000USD24,960,000USD9,113,000USD10,519,000USD——
Long Term Debt22,404,000USD22,321,000USD—22,223,000USD2,478,000USD———
Long Term Investments744,000USD3,206,000USD3,206,000USD9,406,000USD10,630,000USD0USD——
Short Term Investments4,762,000USD413,000USD0USD—————
Net Receivables0USD1,698,000USD12,798,000USD720,000USD488,000USD10,000,000USD965,000USD523,000USD
Accounts Payable296,000USD1,312,000USD2,968,000USD653,000USD1,144,000USD792,000USD2,037,000USD2,218,000USD
Property Plant Equipment Net7,230,000USD10,179,000USD14,601,000USD13,779,000USD29,334,000USD41,500,000USD39,571,000USD21,147,000USD
Property Plant Equipment Gross35,922,000USD38,255,000USD40,089,000USD54,252,000USD53,248,000USD41,500,000USD39,571,000USD21,147,000USD
Common Stock Shares Outstanding12,826,078shares6,883,911shares3,841,405shares2,929,949shares1,956,270shares1,734,391shares1,400,000shares1,634,341shares
Non Current Assets Total35,676,000USD41,399,000USD23,422,000USD39,064,000USD49,744,000USD44,594,000USD41,561,000USD22,925,000USD
Non Current Liabilities Total53,255,000USD65,015,000USD90,933,000USD118,072,000USD84,350,000USD62,904,000USD69,987,000USD84,565,000USD
Non Current Liabilities Other259,000USD194,000USD128,000USD95,849,000USD81,872,000USD392,000USD——
Non Currrent Assets Other26,536,000USD27,392,000USD5,215,000USD19,806,000USD11,520,000USD1,721,000USD558,000USD312,000USD
Net Working Capital109,827,000USD80,009,000USD86,372,000USD139,441,000USD125,774,000USD62,735,000USD166,740,000USD101,600,000USD
Unclassified Non Current Liabilities30,592,000USD42,500,000USD90,805,000USD-93,073,000USD-77,059,000USD8,194,000USD——
Unclassified Equity620,434,000USD538,855,000USD508,490,000USD489,695,000USD408,795,000USD331,450,000USD326,982,000USD131,583,000USD
Current Deferred Revenue—2,957,000USD12,035,000USD46,192,000USD21,244,000USD30,236,000USD16,486,000USD8,436,000USD
Other Assets——1USD9,804,000USD11,520,000USD8,131,000USD558,000USD312,000USD
Short Long Term Debt——22,412,000USD—————
Unclassified Current Liabilities——-22,412,000USD———-6,825,000USD-3,251,000USD
Other Liab———93,073,000USD77,059,000USD54,318,000USD69,987,000USD84,565,000USD
Inventory———7,552,000USD17,434,000USD5,762,000USD9,497,000USD—
Treasury Stock———-952,000USD-952,000USD-952,000USD-952,000USD-952,000USD
Net Tangible Assets———59,085,000USD89,120,000USD43,052,000USD136,882,000USD38,489,000USD
Unclassified Current Assets———-7,552,000USD-17,434,000USD-5,762,000USD-9,497,000USD—
Unclassified Non Current Assets———-14,462,000USD-15,308,000USD-8,131,000USD——
Accumulated Other Comprehensive Income——————-10,649,000USD-5,484,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Quarterly

Exact reported values; units shown beside each amount. Missing values are —.
MetricQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USD
Net Income-18,441,000USD20,133,000USD-21,772,000USD-23,520,000USD-20,565,000USD-17,745,000USD-16,425,000USD32,749,000USD
Depreciation640,000USD678,000USD674,000USD696,000USD705,000USD757,000USD1,011,000USD1,382,000USD
Stock Based Compensation1,549,000USD2,041,000USD2,386,000USD2,937,000USD2,822,000USD3,571,000USD3,199,000USD2,928,000USD
Other Non Cash Items10,171,000USD-11,889,000USD1,557,000USD2,237,000USD-719,000USD-6,167,000USD-3,596,000USD-7,458,000USD
Change To Account Receivables-4,000,000USD-1,465,000USD-4,000USD4,000USD1,694,000USD-151,000USD9,769,000USD183,000USD
Change In Working Capital-5,856,000USD-22,213,000USD1,885,000USD-2,621,000USD-1,295,000USD901,000USD9,899,000USD-44,470,000USD
Total Cash From Operating Activities-11,937,000USD-11,250,000USD-15,270,000USD-20,271,000USD-19,052,000USD-18,683,000USD-5,912,000USD-14,869,000USD
Capital Expenditures-18,000USD-34,000USD-15,000USD-2,000USD-314,000USD-97,000USD-64,000USD-28,000USD
Free Cash Flow-11,955,000USD-11,284,000USD-15,270,000USD-20,273,000USD-19,366,000USD-18,780,000USD-5,976,000USD-14,897,000USD
Total Cashflows From Investing Activities-114,000USD-325,000USD17,000USD-12,000USD-314,000USD-97,000USD-64,000USD-28,000USD
Total Cash From Financing Activities745,000USD77,516,000USD1,659,000USD5,300,000USD10,687,000USD5,920,000USD3,733,000USD702,000USD
Issuance Of Capital Stock662,000USD77,516,000USD1,581,000USD5,300,000USD1,031,000USD5,940,000USD3,613,000USD702,000USD
Change In Cash-11,306,000USD65,941,000USD-17,372,000USD-14,981,000USD-8,679,000USD-12,860,000USD-2,243,000USD-14,195,000USD
Begin Period Cash Flow137,153,000USD71,212,000USD62,242,000USD77,223,000USD108,468,000USD121,328,000USD123,571,000USD137,766,000USD
End Period Cash Flow125,847,000USD137,153,000USD44,870,000USD62,242,000USD99,789,000USD108,468,000USD121,328,000USD123,571,000USD
Other Cashflows From Investing Activities-96,000USD-296,000USD7,000USD—-250,000USD—-25,000USD—
Other Cashflows From Financing Activities745,000USD77,516,000USD1,659,000USD—140,000USD137,000USD120,000USD-28,000USD
Net Borrowings—0USD———-20,000USD——
Unclassified Financing Cash Flow—-77,516,000USD-1,581,000USD—9,516,000USD———
Investments——17,000USD-12,000USD-314,000USD-97,000USD-64,000USD-28,000USD
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Cash flow Yearly

Exact reported values; units shown beside each amount. Missing values are —.
MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
Net Income-45,724,000USD7,167,000USD-61,319,000USD-111,637,000USD-30,602,000USD-109,006,000USD-92,877,000USD-46,037,000USD
Depreciation2,753,000USD4,577,000USD8,255,000USD9,004,000USD10,197,000USD9,813,000USD5,317,000USD2,354,000USD
Stock Based Compensation10,186,000USD12,604,000USD14,040,000USD19,197,000USD16,514,000USD13,786,000USD8,940,000USD2,453,000USD
Other Non Cash Items-8,350,000USD-28,794,000USD-3,603,000USD13,573,000USD-26,546,000USD35,000USD16,280,000USD14,000USD
Change To Account Receivables229,000USD10,422,000USD-181,000USD-232,000USD9,512,000USD-9,035,000USD-441,000USD-523,000USD
Change In Working Capital-24,708,000USD-53,999,000USD-41,487,000USD24,110,000USD19,584,000USD-2,014,000USD-2,357,000USD-10,507,000USD
Total Cash From Operating Activities-65,843,000USD-58,445,000USD-84,114,000USD-45,753,000USD-10,853,000USD-87,386,000USD-73,637,000USD-51,723,000USD
Capital Expenditures-85,000USD-250,000USD-2,278,000USD-3,319,000USD-5,803,000USD-5,031,000USD-24,666,000USD-15,678,000USD
Free Cash Flow-65,928,000USD-58,695,000USD-86,392,000USD-49,072,000USD-16,656,000USD-92,417,000USD-98,303,000USD-67,401,000USD
Total Cashflows From Investing Activities-634,000USD-215,000USD5,829,000USD-3,319,000USD-5,803,000USD-5,031,000USD-24,666,000USD-15,663,000USD
Net Borrowings0USD-37,000USD0USD19,805,000USD-48,000USD2,470,000USD39,550,000USD39,550,000USD
Total Cash From Financing Activities95,162,000USD50,450,000USD5,387,000USD94,985,000USD70,521,000USD1,329,000USD175,996,000USD107,777,000USD
Issuance Of Capital Stock94,944,000USD50,238,000USD2,159,000USD74,345,000USD60,477,000USD35,000,000USD135,185,000USD109,742,000USD
Change In Cash28,685,000USD-8,210,000USD-72,898,000USD45,913,000USD53,865,000USD-91,088,000USD77,693,000USD40,391,000USD
Begin Period Cash Flow108,468,000USD116,678,000USD189,576,000USD143,663,000USD89,798,000USD180,886,000USD103,193,000USD62,802,000USD
End Period Cash Flow137,153,000USD108,468,000USD116,678,000USD189,576,000USD143,663,000USD89,798,000USD180,886,000USD103,193,000USD
Other Cashflows From Investing Activities-549,000USD-25,000USD107,000USD-3,319,000USD-750,000USD——15,000USD
Other Cashflows From Financing Activities95,162,000USD249,000USD401,000USD835,000USD7,574,000USD1,329,000USD-1,361,000USD107,777,000USD
Unclassified Financing Cash Flow-94,944,000USD—2,827,000USD—-4,265,000USD-3,159,000USD—-39,550,000USD
Investments—-215,000USD5,155,000USD-3,319,000USD-5,803,000USD-5,031,000USD-24,666,000USD-15,663,000USD
Unclassified Investing Cash Flow——2,845,000USD6,638,000USD6,553,000USD5,031,000USD24,666,000USD15,663,000USD
Change To Liabilities———153,000USD867,000USD326,000USD-7,199,000USD-3,850,000USD
Sale Purchase Of Stock———74,737,000USD67,260,000USD689,000USD136,446,000USD0USD
Cash And Cash Equivalents Changes———45,913,000USD53,865,000USD-91,088,000USD——
Change To Inventory————4,305,000USD8,013,000USD5,283,000USD-5,946,000USD
Unclassified Operating Cash Flow——————-8,940,000USD—
SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

Operating metrics

No operating metrics are currently published for this company.

Revenue breakdown

PeriodDimensionBusiness / regionRevenueCurrencySource
Q2 2024Quarterly · 2024-06-30ProductCollaboration And License800,000USD0001628280-25-038594
Q2 2024Quarterly · 2024-06-30ProductDevelopment And License48,200,000USD0001628280-25-038594
Q2 2024Quarterly · 2024-06-30ProductLicense900,000USD0001628280-25-038594
Q4 2021Quarterly · 2021-12-31SegmentFood977,000USDLegacy provider
Q4 2021Quarterly · 2021-12-31SegmentTherapeutics5,362,000USDLegacy provider
FY 2021Yearly · 2021-12-31SegmentFood3,806,000USD0001564590-22-010222
FY 2021Yearly · 2021-12-31SegmentTherapeutics111,723,000USD0001564590-22-010222
Q3 2021Quarterly · 2021-09-30SegmentFood1,241,000USD0001564590-21-055930
Q3 2021Quarterly · 2021-09-30SegmentTherapeutics22,795,000USD0001564590-21-055930
Q2 2021Quarterly · 2021-06-30SegmentFood918,000USD0001564590-21-043680
Q2 2021Quarterly · 2021-06-30SegmentTherapeutics67,887,000USD0001564590-21-043680
Q1 2021Quarterly · 2021-03-31SegmentFood670,000USD0001564590-21-027213
Q1 2021Quarterly · 2021-03-31SegmentTherapeutics15,679,000USD0001564590-21-027213
Q4 2020Quarterly · 2020-12-31SegmentFood524,000USDLegacy provider
Q4 2020Quarterly · 2020-12-31SegmentTherapeutics8,322,000USDLegacy provider
FY 2020Yearly · 2020-12-31SegmentFood2,422,000USD0001564590-22-010222
FY 2020Yearly · 2020-12-31SegmentTherapeutics21,863,000USD0001564590-22-010222
Q3 2020Quarterly · 2020-09-30SegmentFood315,000USD0001564590-21-055930
Q3 2020Quarterly · 2020-09-30SegmentTherapeutics7,048,000USD0001564590-21-055930
Q2 2020Quarterly · 2020-06-30SegmentFood58,000USD0001564590-21-043680
Q2 2020Quarterly · 2020-06-30SegmentTherapeutics1,020,000USD0001564590-21-043680
Q1 2020Quarterly · 2020-03-31SegmentFood1,525,000USD0001564590-21-027213
Q1 2020Quarterly · 2020-03-31SegmentTherapeutics5,473,000USD0001564590-21-027213
FY 2019Yearly · 2019-12-31SegmentFood1,606,000USD0001564590-21-014005
FY 2019Yearly · 2019-12-31SegmentTherapeutics20,632,000USD0001564590-21-014005
FY 2018Yearly · 2018-12-31SegmentFood1,360,000USD0001564590-20-009541
FY 2018Yearly · 2018-12-31SegmentTherapeutics9,523,000USD0001564590-20-009541

Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.